Tumour metabolism in chemoprevention




Dr Din speaks with ecancertv at the 2016 BACR and ECMC Joint Meeting about her research into the metabolic processes of aspirin in cancer cells

Using organoid models, she reports on the mechanisms by which aspirin inhibits mTOR signalling and protein regulation.

Dr Din describes the additional impacts of diet, exercise and genetic susceptibility on tumour metabolism, and the population-level outcomes that wider adoption of chemoprevention could contribute towards.

Likes: 0

Viewed:

source


Try Market Samurai For Free!
caretaker

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: